Effect of orally administered magnesium on postoperative pain level and trismus after surgical removal of the lower third molars: a randomized, double-blind, placebo-controlled trial
- 20 May 2020
- journal article
- research article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 24 (12) , 4649-4659
Abstract
Objectives Pain and trismus are the most common postoperative complications following a surgical removal of the lower third molar. This randomized, double-blind, placebo-controlled clinical trial evaluated the effect of orally administrated magnesium on postoperative pain and trismus after surgical removal of the lower third molars. Materials and methods The study was conducted on 80 participants who were divided into two groups. Each group took different oral forms of magnesium citrate. Participants in both groups had their two lower molars surgically removed. For one randomly selected third molar, participants received either magnesium citrate tablets or lozenges. For the surgical removal of the lower third molar of the opposite side, the participants received either placebo tablets or lozenges. The data were analyzed using the Wilcoxon signed-ranked test, the Mann-Whitney U test, and the Spearman rank-order correlation with the level of significance set at p < 0.05. This manuscript was written in accordance with the Consort recommendation. Results The results show a statistically significant lower pain level at all tested times (24 h, 48 h, and 72 h postoperatively) for participants who used magnesium preparations in lozenges (p = 0.012, p = 0.013, and p ≤ 0.001) as well as in tablet form (p ≤ 0.001) compared to placebo. The results also show a statistically significant greater mouth opening ability at all tested times (24 h, 48 h, and 72 h postoperatively) between magnesium preparations and the placebo (p ≤ 0.001). Conclusion Orally administered magnesium (either lozenges or tablets) before and after a lower third molar surgical removal significantly reduces pain intensity and the degree of trismus in the postoperative period. Clinical relevance Based on the results of the study, oral magnesium could be used in the oral and maxillofacial surgery to reduce postoperative complications after surgical removal of the lower third molars. Trial registration This study is registered on http:clinicaltrials.gov under protocol no. NCT03398382.Keywords
This publication has 44 references indexed in Scilit:
- Ambulatory oral surgery: 1-year experience with 11 680 patients from Zagreb district, CroatiaCroatian Medical Journal, 2013
- Limited mouth opening after primary therapy of head and neck cancerOral and Maxillofacial Surgery, 2010
- An evidence‐based update of the use of analgesics in dentistryPeriodontology 2000, 2008
- Quality of life following lower third molar removalInternational Journal of Oral and Maxillofacial Surgery, 2006
- Rescue treatment and prevention of asthma using magnesium throat lozenges: Hypothesis for a mouth–lung biologically closed electric circuitMedical Hypotheses, 2006
- Clinical postoperative findings after removal of impacted mandibular third molars: prediction of postoperative facial swelling and pain based on preoperative variablesBritish Journal of Oral and Maxillofacial Surgery, 2004
- Magnesium infusion reduces perioperative painEuropean Journal of Anaesthesiology, 2002
- Magnesium infusion reduces perioperative painEuropean Journal of Anaesthesiology, 2002
- Magnesium as part of balanced general anaesthesia with propofol, remifentanil and mivacurium: a double-blind, randomized prospective study in 50 patientsEuropean Journal of Anaesthesiology, 2001
- Magnesium as part of balanced general anaesthesia with propofol, remifentanil and mivacurium: a double-blind, randomized prospective study in 50 patientsEuropean Journal of Anaesthesiology, 2001